MIF and scleroderma: In 2003, Selvi et al. reported that the serum concentrations of MIF in patients with diffuse form of systemic sclerosis were significantly higher than those in controls and MIF expression was detected in skin biopsies of scleroderma patients by immunohistochemical staining [22].